NDC 70010-114 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 3.125 mg/1; Amphetamine Aspartate Monohydrate 3.125 mg/1; Dextroamphetamine Sulfate 3.125 mg/1; Amphetamine Sulfate 3.125 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC70010-114

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Granules Pharmaceuticals Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA215771
Marketed since
March 28, 2023
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (2)

Package NDCDescriptionSince
70010-114-01100 TABLET in 1 BOTTLE (70010-114-01)Mar 28, 2023
70010-114-0330 TABLET in 1 BOTTLE (70010-114-03)Apr 30, 2024

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products